Schistosomiasis Vaccine:Research to Development
- 1 March 1998
- journal article
- Published by Elsevier in Parasitology Today
- Vol. 14 (3), 99-104
- https://doi.org/10.1016/s0169-4758(97)01207-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Human schistosomiasis: potential long term consequences of vaccination programmesVaccine, 1997
- Adjuvants—a classification and review of their modes of actionVaccine, 1997
- IL-4 in SchistosomiasisExperimental Parasitology, 1996
- Schistosomiasis Japonica in the Philippines: The Long-Term Impact of Population-Based Chemotherapy on Infection, Transmission, and MorbidityThe Journal of Infectious Diseases, 1996
- A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.Proceedings of the National Academy of Sciences, 1996
- Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S‐transferase cloned from S. mansoniParasite Immunology, 1995
- Prospects for immunological control of schistosomiasisThe Lancet, 1995
- Controlling schistosomiasis by vaccination: A realistic option?Parasitology Today, 1995
- Schistosomiasis vaccine development: approaches and prospectsMemórias do Instituto Oswaldo Cruz, 1995
- Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.Proceedings of the National Academy of Sciences, 1988